T. Marchbank et al., HUMAN PANCREATIC SECRETORY TRYPSIN-INHIBITOR - DISTRIBUTION, ACTIONS AND POSSIBLE ROLE IN MUCOSAL INTEGRITY AND REPAIR, Digestion, 59(3), 1998, pp. 167-174
Pancreatic secretory trypsin inhibitor is a potent protease inhibitor
which was originally identified in the pancreas. It has subsequently b
een shown to be present in mucus-secreting cells throughout the gastro
intestinal tract and also in the kidney, lung and breast. Its major ro
les are likely to be to prevent premature activation of pancreatic pro
teases and to decrease the rate of mucus digestion by luminal protease
s within the stomach and colon. In addition, PSTI increases the prolif
eration of a variety of cell lines and stimulates cell migration, poss
ibly acting via the EGF receptor. These findings suggest that PSTI may
also be involved in both the early and late phases of the healing res
ponse following injury. Further studies including the production of tr
ansgenic overexpression and knockout models should help elucidate the
physiological function of this peptide.